Pharmacy

Familiar antidepressants with a complementary mechanism

Lucin medications are SSRIs+, combination medications between prescriptive L-methylfolate ca (vitamin B9 derivative) and SSRIs, which has been shown to increase efficacy without increasing side effect portfolio.

From research out of

Introducing Lucin, exclusive to Lume

Sertralucin

SERTRALINE (active ingredient of Zoloft®) and L-METHYLFOLATE CA (active ingredient of Deplin FC®)

Learn more

Citalucin

CITALOPRAM (active ingredient of Celexa®) and L-METHYLFOLATE CA (active ingredient of Deplin FC®)

Learn more

Fluoxelucin

FLUOXETINE (active ingredient of Prozac®) and L-METHYLFOLATE CA (active ingredient of Deplin FC®)

Learn more

Escilucin

ESCITALOPRAM (active ingredient of Lexapro®) and L-METHYLFOLATE CA (active ingredient of Deplin FC®)

Learn more

Prescription required.

What the research shows

Research on L-methylfolate ca augmented SSRIs

1 .Papakostas G, et al. Am J Psychiatry. 2012;169:1267-1274.
2. Zajecka JM, et al. Journal of Clinical Psychiatry. 2016;77(5):654-660.
3. Zajecka MJ. J Clinical Psychiatry. 2016; 654-60

Reduces symptoms up to 84%

Compared to SSRI monotherapy, adjunctive prescriptive L-methylfolate reduced depressive symptoms by up to 84%.¹

No additional SSRI specific side effects

Adjunct L-methylfolate in clinical trials was comparable to placebo (sugar pill) in tolerability and side effect portfolio.²

Symptom improvement in 30 days

Patients saw symptom improvement in as little as 30 days, with 50% of patients achieving full remission at 12 months.^1,3

1 .Papakostas G, et al. Am J Psychiatry. 2012;169:1267-1274.
2. Zajecka JM, et al. Journal of Clinical Psychiatry. 2016;77(5):654-660.
3. Zajecka MJ. J Clinical Psychiatry. 2016; 654-60